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Key points
●● Physiological changes are observed following a structured exercise training programme in patients 
with COPD, without changes in resting lung function.
●● Exercise training is the cornerstone of a comprehensive pulmonary rehabilitation programme in 
patients with COPD.
●● Most comorbidities in patients referred for pulmonary rehabilitation remain undiagnosed and 
untreated.
●● After careful screening, it is safe for COPD patients with comorbidities to obtain significant and 
clinically relevant improvements in functional exercise capacity and health status after an exercise-
based pulmonary rehabilitation programme.
Educational aims
●● To inform readers of the positive effects of exercise-based pulmonary rehabilitation in patients with 
COPD, even with comorbid conditions.
●● To inform readers of the importance of physical activity in patients with COPD.
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Summary
Physical activity is defined as any bodily move-
ment produced by skeletal muscles which results 
in energy expenditure. Physical activity in daily 
life can be categorised into occupational, sports, 
conditioning, household, or other activities. Exer-
cise is a subset of physical activity that is planned, 
structured, and repetitive and has as a final or 
an intermediate objective the improvement or 
maintenance of physical fitness [1]. According to 
international guidelines, exercise training, widely 
regarded as the cornerstone of pulmonary reha-
bilitation, is the best available means of improv-
ing muscle function and exercise tolerance in 
patients with chronic obstructive pulmonary 
disease (COPD) [2, 3]. It truly makes a difference 
in the life of patients with COPD. In this review, 
an overview is provided on the history of exercise 
training (as standalone intervention or as part 
of a comprehensive pulmonary rehabilitation 
programme), the state-of-the-art exercise train-
ing, exercise training in comorbid patients with 
COPD, and the impact of physical activity coun-
selling in a clean air environment.
The history of exercise-based 
pulmonary rehabilitation
In 1894, Baron Pierre de Coubertin founded the 
International Olympic Committee (IOC). During the 
first IOC Congress (organised in Paris from June 16 to 
23 1894), it was decided that the inaugural Olympic 
Games to come under the auspices of the IOC would 
take place in Athens in 1896 [4]. At the same time, 
Dr Denison, professor of Diseases of the Chest and 
of Climatology at University of Denver, published a 
book with the inspiring title “Exercise and food for 
pulmonary invalids”, in which he emphasised the 
importance of physical exercise and healthy food 
for the health of “pulmonary invalids” [5]. This was 
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most probably the first publication in which the use 
of exercise training as part of disease management 
of chronic lung disease was recommended.
More than 50 years later, in 1952, Barach 
et al. [6] reported that enhancement in capacity 
to walk without breathlessness can result in a 
 physiological response similar to a training pro-
gramme in athletes. Indeed, in two patients with 
pulmonary emphysema in whom dyspnoea on 
exertion was relieved during inhalation of oxygen, 
an exercise programme was started with subse-
quent remarkable improvement of capacity to 
exercise without oxygen [6]. The same research 
group again recommended in 1964 the use of 
exercise training: “It may seem unusual perhaps to 
suggest exercise to these breathless people, but in 
fact it is one of the ways by which they can restore 
physical fitness.” [7]. Noehren et al. [7] also sug-
gested that physical inactivity may play an import-
ant role in the observed physical deconditioning: 
“I am unhappy about patients who always use an 
elevator to go up stairs” and “The muscles in the 
legs of these people are very often atrophied”. Five 
years later, Petty et al. [8] were the first to describe 
the effects of a comprehensive care programme 
for people with “chronic airway obstruction”. The 
programme consisted of multidisciplinary base-
line evaluation, followed by individual instructions 
for bronchial hygiene, breathing retraining, graded 
exercises (daily, for 1 h), and even a home visit by 
the nurse. Finally, outcome evaluation took place 
during the programme, at the end of the pro-
gramme and 1 year later. They reported positive 
effects on multiple outcomes, ranging from daily 
symptoms and exercise tolerance, up to a return 
to gainful employment and healthcare utilisa-
tion. The total number of hospital days (n=868), 
the number of hospitalised patients (n=34, which 
equaled 22.4% of the total sample) and the mean 
length of stay (25 days) in the year before the pro-
gramme were clearly higher compared with the 
first year of the programme (n=542, 25 and 21.7, 
respectively) [8]. This was the first proof that a 
comprehensive care programme including graded 
exercise training improved healthcare utilisation 
in patients with “chronic airway obstruction”.
In 1970, Bass et al. [9] were among the first to 
assess the true change in exercise performance 
in symptomatic COPD patients with dyspnoea 
either during walking at an ordinary pace on 
level ground or during washing or dressing and 
with the motivation to lead a more active life. 
After 18 weeks of a stationary cycle-based exer-
cise training programme, patients with COPD 
improved their maximal work load by about 85% 
compared with baseline. In addition, 92% of the 
patients claimed that they could “do more” and 
reported an increase in daily physical activity 
[9]. Indeed, these authors pioneered a study to 
assess physical activity levels using a pedome-
ter (unfortunately without any specification) and 
daily activities using a diary. Moreover, they were 
also the first to describe the negative impact of 
“acute bronchitis” on the level of physical activity 
[9]. Only 36 years later, Pitta et al. [10] objecti-
fied the decline in physical activity levels during 
an exacerbation-related hospitalisation, using a 
validated accelerometer.
In 1981, the first official ATS Statement on Pul-
monary Rehabilitation was published, in which 
pulmonary rehabilitation was defined as “an art of 
medical practice wherein an individually tailored, 
multidisciplinary programme is formulated which 
through accurate diagnosis, therapy, emotional 
support and education, stabilises or reverses both 
the physio- and psychopathology of pulmonary 
diseases and attempts to return the patient to 
the highest possible capacity allowed by his pul-
monary handicap and overall life situation” [11]. 
In 1992 [12], 1999 [13], 2006 [14] and 2013 
[3] subsequent updates were published, keeping 
in line with the ongoing scientific developments. 
Exercise training was always identified as a car-
dinal component of pulmonary rehabilitation for 
patients with COPD.
Also in 1981, Belman and Kendregan [15] 
published new data on the changes in quadri-
ceps muscle structure following exercise train-
ing in patients with COPD. Five men and two 
women underwent 6-week lower limb cycle train-
ing, starting at approximately one-third of the 
maximum load reached in the incremental test. 
Despite a high compliance (mean attendance was 
45 sessions out of the maximum 48 sessions), the 
improvement in exercise performance was only 
observed in about half of the patients. Moreover, 
activity of the oxidative enzymes citrate synthase, 
3-β-hydroxyacyl CoA dehydrogenase and pyru-
vate kinase in the biopsy specimens of the quadri-
ceps lateralis muscle did not change significantly 
compared with baseline [15]. So, the authors 
concluded that the improvements in exercise tol-
erance following exercise training were probably 
due to an increased motivation, desensitisation 
to dyspnoea, improved skills, or a combination 
thereof; but not due to true physiological changes 
at the level of the lower-limb muscles [15]. At 
first sight, the lack of improvement in muscle 
enzyme activity came as a surprise. Nevertheless, 
the training intensity was most probably too low 
to increase enzyme activity at all, which was also 
commented upon by others [16].
In 1991, Casaburi et al. [17] did report a reduc-
tion in exercise-induced lactate and ventilation at 
iso-time during a constant work rate cycling test 
following exercise-based pulmonary rehabilitation, 
in particular in COPD patients who performed their 
exercise training at high work rates. So, improve-
ment in exercise performance following exercise 
training at moderate-to-high intensity was pro-
posed to be related, at least in part, to physiologi-
cal changes at the level of the lower-limb muscles. 
In 1996, Maltais et al. [18] did provide evidence 
that exercise training can result in physiological 
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changes, including an increased oxidative enzyme 
activity (i.e., citrate synthase and 3-hydroxyacyl-CoA 
dehydrogenase) and a reduced exercise-induced 
lactate production, following a 12-week aerobic 
training programme in patients with COPD. This 
truly provided a strong scientific basis for exercise 
training as a cornerstone of pulmonary rehabilita-
tion in patients with COPD. Indeed, Ries et al. [19] 
already demonstrated in 1995 that exercise train-
ing in combination with education resulted in a sig-
nificantly greater increase in exercise performance 
compared with education alone in 128 patients 
with COPD. These authors, however, did not assess 
the metabolic changes within the lower-limb mus-
cles. So, whole-body endurance exercise training 
was the common standard for pulmonary rehabil-
itation in patients with COPD. In 1997, however, 
Maltais et al. [20] demonstrated that a majority of 
patients with COPD were unable to perform aerobic 
exercise at a high intensity. Therefore, other train-
ing modalities were introduced for patients with 
COPD, including interval training (which will be dis-
cussed in depth later in the article) [21].
In 1992, Simpson et al. [22] started with the 
evaluation of the efficacy of weightlifting exercises 
in patients with COPD. 34 patients were randomly 
assigned to 8 weeks of weightlifting or usual care. 
Training sessions were held three times a week for 
8 weeks. Weight lifting consisted of 10 repetitions 
of single arm curl, single leg extension and single 
leg press exercise, which were repeated three times. 
The resistance was increased progressively from 
50% of one repetition maximum during the first 
week to 85% during the final week of training. The 
one repetition maximum for all the exercises was 
re-evaluated every sixth session and adjusting the 
resistance in terms of the most recent maximum 
ensured a constant relative training stimulus. Sub-
jects were coached and observed to obtain a slow 
smooth movement with normal breathing control 
during the lifting phase of the exercise. Resistance 
training significantly increased muscle strength, 
while no changes were observed in the usual care 
control group. Maximal incremental exercise capac-
ity and 6-min walk distance did not change follow-
ing the 8 weeks of resistance training. In contrast, 
mean±sd endurance to fatigue during cycling at 
80% of maximum exercise capacity improved sig-
nificantly from 518±69 s to 898±95 s (p<0.01), but 
was unaffected in the usual care control group. Also, 
the domains “dyspnoea”, “fatigue” and “mastery” 
of the Chronic Respiratory Questionnaire improved 
significantly following resistance training. So, local 
muscle training improved lower-limb muscle 
function, exercise endurance and quality of life in 
patients with COPD [22]. Afterwards, multiple stud-
ies have confirmed the positive effects of resistance 
training in patients with COPD, as summarised by 
O’Shea et al. [23]. Meanwhile, it is very well known 
that a lower metabolic cost of local muscle training 
results in a lower burden on the impaired ventila-
tory system compared with whole-body endurance 
training [24]. In turn, this type of training is espe-
cially suitable for COPD patients with low ventilatory 
reserve and severe dyspnoea. Besides resistance 
training, other  training modalities have also been 
introduced over the past 15 years. Indeed, there are 
beneficial effects reported on lower-limb muscle 
function, exercise performance and quality of life in 
patients with COPD following neuromuscular elec-
trical stimulation [25], water-based training [26], 
one-legged cycling [27], Tai Chi [28], Nordic walking 
[29], whole-body  vibration [30] and non-linear exer-
cise training [31].
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To date, the most optimal format of exercise 
training (i.e., type, intensity, frequency and dura-
tion) for patients with COPD is still subject to 
investigation. Accordingly, the major issue of inter-
est has been the selection of the appropriate train-
ing method that is tailored to the cardiovascular, 
pulmonary and peripheral muscle limitations of 
the individual patient so as to maximise the effect 
of exercise conditioning. Although high-intensity 
constant-load exercise is generally argued to be 
needed for an improvement in exercise capacity 
[31], ventilatory limited patients and those with 
profound muscle weakness are usually unable to 
sustain high exercise intensities for sufficiently 
long periods [19]. An alternative approach that 
allows high-intensity exercise to be performed 
for sufficiently long periods of time to achieve 
true physiological effects is interval exercise. This 
form of exercise comprises a sequence of on-and 
off-high intensity muscular loading events with 
tolerable levels of dyspnoea sensations [32]. In 
healthy trained individuals, application of interval 
exercise allows heavy loads to be imposed upon 
both peripheral muscles and oxygen-transport-
ing organs without a profound engagement of 
anaerobic processes. This reduction in metabolic 
acidosis, allows a greater amount of work to be 
performed before exhaustion sets in [33].
The paradigm of sail pumping in Olympic-class 
windsurfing is representative of the advantages of 
interval exercise. Sail pumping is a highly demand-
ing endurance manoeuvre in which the athlete 
rhythmically pulls a 9.5 m2 sail so that it acts as 
a wing, thus providing the board with additional 
forward motion in light and moderate wind con-
ditions. Accordingly, in a typical regatta, lasting 
30–45 min, metabolic acidosis is likely to present 
a limiting factor to muscle performance, especially 
in the relatively small but hard working muscles 
of the upper body [34]. This is the reason why 
 Olympic-class windsurfers set pumping frequen-
cies at or slightly above the exercise intensity that 
represents the lactate threshold.
The accessibility of portable gas exchange and 
lactate analysers has allowed exercise scientists 
to determine the lactate threshold of the indi-
vidual sailor during sea training. Typically wind-
surfers alternate periods (15–30 s) of high- and 
lower-frequency pumping actions so as to main-
tain oxygen uptake and heart rate recordings to 
levels corresponding to their lactate threshold 
[35, 36]. In patients with advanced COPD, interval 
exercise consisting of repeated bouts (30–60 s) of 
high- or even maximal-intensity work (80–100% 
peak) separated by periods (30–60 s) of lower 
intensity work intervals, has been shown to be 
associated with a small increase in arterial lactate 
concentration, lower ventilation and degrees of 
dynamic hyperinflation and lower symptoms of 
dyspnoea and leg discomfort, thus allowing the 
total amount of work performed to be significantly 
greater than that of constant-load exercise [37]. 
Implementation of high-intensity interval training 
in patients with COPD has proven to be effective 
in terms of improvements in vastus lateralis cap-
illarisation and muscle fibre oxidative capacity, 
thus enhancing the utilisation of oxygen by the 
exercising muscles [38]. Furthermore, this type 
of training is effective in reducing the magnitude 
of exercise-induced dynamic hyperinflation and 
associated dyspnoea sensations [39], as well as 
improving central haemodynamic responses [40] 
during exercise in patients with COPD.
Exercise in comorbid patients 
with COPD
Comorbidities, defined as the presence of one or 
more additional disorders co-occurring with COPD, 
are incorporated in the definition of the disease as 
it is recognised that they impact on the burden of 
disease in individual patients [41]. Comorbidities 
such as diabetes, hypertension and cardiovascular 
disease, increase the risk of hospitalisation [42] and 
mortality [43]. While smoking is an obvious risk fac-
tor for the development of other chronic diseases 
in COPD, the prevalence of several comorbidities, 
including coronary artery disease, hypertension, 
osteoporosis and anxiety, is higher in smokers than 
non-smokers [44]. This suggests that additional 
risk factors exist in COPD; low physical activity, sys-
temic inflammation, accelerated ageing and poor 
diet probably contribute to the development of 
(specific) comorbidities in individual patients [45].
Most patients referred for pulmonary reha-
bilitation suffer from one or more comorbidi-
ties [46]; thus, it is important to consider their 
impact on the efficacy and safety of and patient 
compliance during an exercise-based pulmonary 
rehabilitation programme. Several studies have 
investigated the impact of individual comor-
bidities on outcomes of pulmonary rehabilita-
tion [47]. The results of these studies are rather 
inconclusive; the majority of studies had a retro-
spective design, focused on different individual 
comorbidities and the diagnoses of comorbidi-
ties were mostly based on self-report or medical 
records. Moreover, it was recently shown that 
most comorbidities in patients referred for pul-
monary rehabilitation remain undiagnosed and 
untreated [48], suggesting that clinicians and 
scientists should actively search for the impactful 
comorbidities. One of the few prospective studies 
was performed by Crisafulli et al. [49], including 
patients with moderate to severe COPD partici-
pating in a comprehensive outpatient pulmonary 
rehabilitation programme. Only the presence of 
osteoporosis was inversely related to improve-
ment in functional exercise tolerance. Neither did 
the number of comorbidities affect the outcomes 
of exercise-based pulmonary rehabilitation, nor 
did the adherence to the programme differ across 
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comorbidity categories [44]. Recently, Mesquita 
et al. [50] studied the impact of thirteen objec-
tively identified comorbidities on pulmonary 
rehabilitation outcomes. None of the individual 
comorbidities changed the likelihood for a clin-
ically meaningful change in exercise tolerance 
or health status. Also, the number of comorbid-
ities did not affect the outcomes. These findings 
suggest that it is safe to for patients with COPD 
and comorbidities to obtain significant and clin-
ically relevant improvements in functional exer-
cise capacity and health status after a pulmonary 
rehabilitation programme. Obviously, diagnosis 
and adequate treatment of impactful comor-
bidities in patients referred for exercise-based 
pulmonary rehabilitation is important. Unstable 
central and peripheral cardiovascular disease, 
severely impaired cognitive functioning and seri-
ous musculoskeletal problems are among the few 
contra-indications for pulmonary rehabilitation 
and need to be addressed during pre-rehabilita-
tion assessment [51]. Also, ongoing monitoring 
for symptoms and signs of unstable health during 
the course of pulmonary rehabilitation is war-
ranted [47]. In addition to state-of-the art diag-
nostic tools and facilities, this requires specific 
expertise and an interdisciplinary approach from 
healthcare professionals involved in pulmonary 
rehabilitation. Additional studies are warranted 
to identify whether specific programme modi-
fications for patients with co-occurring medi-
cal conditions will enhance the gains in various 
outcomes following pulmonary rehabilitation for 
patients with differing comorbidities.
Beneficial effects of exercise-based pulmonary 
rehabilitation on comorbidities have also been 
reported. Exercise-based pulmonary rehabilitation 
was significantly more effective in reducing short-
term anxiety and depression than standard care 
[52]. Reductions in pulse wave velocity, a marker 
of cardiovascular risk have also been reported after 
exercise-based pulmonary rehabilitation [53, 54], 
although a larger observational study did not con-
firm this [55]. This highlights the complex and 
heterogeneous pathophysiology of cardiovascular 
disease in COPD. Finally, the effects of nutritional 
supplementation and/or counselling and exercise 
training as a part of pulmonary rehabilitation on 
body weight, muscle mass and structural skeletal 
muscle abnormalities are well-recognised [56]. 
Recently, positive effects of a specific pulmonary 
rehabilitation programme aimed at obese COPD 
patients were reported for the first time [57].
Exercise training as part of 
a comprehensive pulmonary 
rehabilitation programme
Even though it has been difficult so far to quantify 
the added value of non-exercise components to 
the effectiveness of pulmonary rehabilitation, sev-
eral of these interventions are frequently incorpo-
rated into these programmes and are considered 
to be clinically relevant [58, 59]. These treat-
ment strategies are frequently addressing psy-
chosocial and lifestyle changes associated with 
chronic respiratory conditions with the aim of 
teaching patients how to better manage impair-
ments and to reduce symptom burden. They 
have been designed to address a broad range of 
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issues including treatments to facilitate smoking 
cessation, optimising pharmacotherapy, assist-
ing with early identification and treatment of 
acute exacerbations, managing acute dyspnoea, 
increasing participation in physical activity, 
improving body composition, promoting mental 
health and establishing social support networks 
[60, 61]. Treatments are offered by a dedicated, 
interdisciplinary team, including physicians, 
physiotherapists, respiratory therapists, nurses, 
psychologists, behavioural specialist, exercise 
physiologists, nutritionists, occupational thera-
pists and social workers [3]. Education is consid-
ered an important component of comprehensive 
pulmonary rehabilitation and is integrated into 
virtually all programmes [59]. In addition to 
standard didactic sessions, education may also 
include instructions on how to incorporate 
breathing strategies, such as pursed-lip breath-
ing into daily life. Also instructions on energy 
conservation and work simplification techniques 
can be included. In many programmes these edu-
cational components are embedded within an 
intervention provided by an occupational ther-
apist. Dyspnoea is the most disabling symptom 
for people with COPD and is often the reason 
that medical attention is sought. Strategies that 
have been demonstrated to ameliorate dyspnoea, 
other than participating in supervised exercise 
training, include adopting a forward-leaning sit-
ting position, pursed lip breathing and the use of 
a rollator (or four-wheeled walker) to assist with 
ambulation [62–64]. Together with inspiratory 
muscle training, these treatments are likely to 
reduce the sensation of unrewarded inspiration 
that is perceived as dyspnoea [64]. These strat-
egies are useful to implement within the context 
of pulmonary rehabilitation, as people have the 
opportunity to utilise them both during periods 
of increased dyspnoea associated with super-
vised exercise training as well as during physical 
activities performed in daily life. Psychosocial and 
behavioural interventions in pulmonary rehabili-
tation may include educational sessions focusing 
on specific problems such as stress manage-
ment, instructions in relaxation exercises, panic 
control, smoking cessation, assisting with early 
detection and treatment of acute exacerbations, 
and stimulating participation in regular physical 
activity [3]. Anxiety, depression and difficulties in 
coping with chronic disease are common in COPD 
patients and contribute to morbidity.  Informal 
 discussions during rehabilitation sessions of 
symptoms,  concerns and problems common to 
COPD patients may be beneficial [3]. Individu-
als with major psychiatric conditions should be 
referred to appropriate professionals. Weight 
loss and muscle wasting, which are present in 
20–35% of patients with stable COPD, contribute 
to morbidity and mortality in COPD, independent 
of the pulmonary physiological abnormality [65]. 
Nutritional interventions should be considered 
for these patients, especially while experiencing 
increased exercise-related energy expenditure 
during participation in the programme. There 
is also an increasing number of individuals with 
chronic respiratory diseases and coexisting obe-
sity referred for pulmonary rehabilitation [3]. This 
specific group my benefit from targeted inter-
ventions in addition to exercise training, includ-
ing nutritional education, restricted calorie meal 
planning, encouragement for weight loss and 
psychological support.
Physical activity coaching
Patients with COPD are markedly inactive in daily 
life, showing a decrease in the amount of time 
spent actively, a decreased intensity of activities 
and an increase of sedentary periods throughout 
the day [66]. Symptoms of breathlessness and 
fatigue during physical activities are associated 
with activity-avoiding behaviour which will in 
turn exacerbate the experienced symptoms due 
to deconditioning. In recent years, daily physical 
activity has become a key target for intervention 
trials aiming to improve long-term health sta-
tus [67]. Indeed, physical activity levels play a 
key role in the onset of muscle dysfunction and 
deconditioning and have been associated with 
quality of life, hospital admission, comorbidities, 
lung function decline and mortality [67–71]. To 
date, evidence is lacking that an increase in phys-
ical activity following a specific intervention will 
reduce the burden of COPD. Only observational 
studies show that patients with COPD with a 
low level of physical activity or who reduced their 
physical activity over time are expected to experi-
ence a significant increase in hospitalisation and/
or mortality rate [71, 72].
Unfortunately, improvements in muscle func-
tion and exercise tolerance after pulmonary 
rehabilitation do not automatically translate into 
enhanced physical activity behaviour [73]. Induc-
ing such a behavioural change seems to be more 
complex than simply improving physical capacity 
[74]. Along with socio-demographic and environ-
mental factors, patients’ health beliefs, perception 
of symptoms, self-efficacy and motivation are 
likely to impact on physical activity levels. Social 
support, the option to participate in group activ-
ities, the perceived benefit and the availability of 
professional support are frequently reported as 
enablers of physical activity behaviour [75, 76]. 
The importance of these aspects varies among 
individuals.
Now, it is clear that a more individually tailored 
and comprehensive intervention is warranted to 
effectively target human behaviour. The recent 
official European Respiratory Society Statement 
on Physical Activity in COPD summarises the key 
components that increase the effectiveness of 
behavioural interventions that include mobilising 
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social support, using well-described/established 
behaviour change and self-regulatory techniques 
(i.e., self-monitoring, stimulus control, problem 
solving, relapse prevention management, goal 
setting, self-reinforcement, providing feedback 
on performance and developing action plans), 
providing higher contact time or contact fre-
quency, and assessing the readiness and motiva-
tion to change [67].
Principles of motivational interviewing have 
been used to obtain lifestyle changes in several 
health behaviours including smoking, dietary hab-
its, substance abuse and physical activity. In terms 
of physical activity behaviour, this patient-cen-
tered approach focuses on the identification of 
personal barriers and enablers towards daily phys-
ical activity and stimulates the patients to actively 
search for solutions to overcome existing barriers. 
Enhancing motivation and self-efficacy to impact 
on physical activity behaviour is key in the process. 
In COPD, the addition of an individually tailored 
activity counselling programme, using motiva-
tional interviewing and goal setting strategies, 
on top of a pulmonary rehabilitation programme 
failed to increase physical activity levels [77].
Direct feedback from a pedometer or an activity 
monitor seems to be an important tool to optimise 
the success rate of physical activity counselling 
programmes [78]. Several trials have reported a 
marked increase in physical activity after coun-
selling interventions using real-time activity feed-
back, both as a stand-alone intervention and on 
top of pulmonary rehabilitation [79–81]. Mobile 
phone applications might play an important role 
during these interventions in the future [80]. This 
type of approach challenges patients with COPD 
to meet their daily goals and provides an instant 
reward, but the question remains whether this 
effect fades away with time. Unfortunately long-
term follow-up outcomes have not yet been 
reported in literature.
One key to success in changing physical activity 
behaviour is to identify activities that patients truly 
love to perform. An Austrian trial on the effect of 
a 3-month Nordic walking programme reported 
that increased physical activity levels were sus-
tained 6 months after the end of the trial [29]. 
 Interestingly, over 60% of the patients adopted 
Nordic walking as a hobby. In line with this, a 
Spanish trial showed that patients who were 
offered access to a series of 32 local urban walking 
circuits (including information on public transport 
and cultural and commercial places of interest on 
the road; with varying difficulty and length) after 
finalising a short pulmonary rehabilitation pro-
gramme increased physical activity levels up to 
9 months after the end of the programme [82]. 
The latter strategy fits with current approaches 
to integrate health-promoting physical activity in 
daily routines. This is also termed active mobility, 
namely walking and cycling for transport solely or 
in combination with public transport [83]. Active 
mobility is economically affordable for most peo-
ple, and provides an equitable and accessible form 
of physical activity. As such, it has the potential 
to reach population groups that are unresponsive 
to appeals and benefits of leisure time physical 
activity. Several studies already demonstrate the 
net health benefit of active mobility [84].
Even after successful behaviour change, 
patients might experience a relapse. Acute exac-
erbations of the disease are important reasons 
for prolonged inactivity [85]. Patients frequently 
identify exacerbations of the disease as an 
important barrier to exercise [75]. Unfortunately, 
a recent trial investigating the effectiveness of a 
physical activity counselling programme initiated 
during hospitalisation for an exacerbation failed 
to enhance physical activity levels in comparison 
to natural recovery [86]. Nevertheless, as exacer-
bations are key events in light of relapse within 
the behaviour-change process, they might be 
important moments for adequate monitoring and 
support in terms of physical activity behaviour by 
health professionals.
So, an increase in (outdoor) daily physical 
activity is expected to have a health benefit in 
patients with COPD [74]. However, outdoor exer-
cise and active mobility may be associated not 
only with health benefits, but also with certain 
health risks in an urban environment. Indeed, the 
higher minute ventilation during physical activ-
ity, greater deposition fraction, a greater total 
particle deposition over the course of an exercise 
bout and oral breathing could all increase the 
dose (the amount deposited and retained in the 
body) of traffic-related air pollutants [87]. Air pol-
lution is a heterogeneous mixture of compounds 
in gaseous (e.g. ozone, carbon monoxide, sulfur 
dioxide, nitrogen oxides), liquid and solid phases 
that can cause harm. Besides ozone, particulate 
matter (PM) appears to be the most widespread 
and harmful of air pollutants. PM is an air-sus-
pended mixture of solid and liquid particles that 
vary in origin, chemical composition and physical 
properties [88]. PM is subdivided into categories 
based on the particle’s aerodynamic diameter 
(particles <10 μm (PM10; the thoracic particles, 
i.e. those capable of passing beyond the larynx 
during inhalation); particles <2.5 μm (PM2.5; fine 
particles) and particles <0.1 μm, the ultrafine 
particles (UFP). A large amount of research has 
demonstrated harmful effects of short- and long-
term PM exposure on the respiratory and cardio-
vascular system, even at low PM levels. It is now 
well established that inhalation of PM induces 
adverse cardiovascular and pulmonary events, 
which underlie increased morbidity and mortality 
rates [89].
The issue of potential harmful health effects 
of air pollution has received ample media atten-
tion in the past during several Olympic Games, 
for which there was a major concern for the 
health and performance of competing athletes 
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[90, 91]. Marr and Ely [92] found a correlation 
between PM levels and impaired performance 
in female marathon runners. Cutrufello et al. 
[90] described in their review that exposure to 
ambient air pollution during exercise can reduce 
performance, decrease lung function and lead 
to endothelial dysfunction. Exercise in polluted 
air may lead to acute  pulmonary effects, e.g. 
temporary decreases in lung function [93, 94], 
increased levels of inflammatory markers and 
altered immune function in the pulmonary sys-
tem [95, 96] and acute cardiovascular effects, 
e.g. impaired vasodilation [97, 98]. Other studies 
suggest neuroinflammatory effects when exer-
cise in urban environment is being compared 
with exercise in clean air [99, 100], although the 
number of human studies is too limited to draw 
firm conclusions on this matter [101]. Altered 
cardiac autonomic function, changes in vascular 
function, oxidative stress and inflammation are 
potential pathophysiological pathways through 
which particulate air pollution can influence its 
effects [102–104]. Exercise and air pollution 
impinge on the same physiological mechanisms 
and health outcomes. Arterial compliance, exer-
cise-induced hypotension and exercise-induced 
bronchodilatation may offset the effects of air 
pollution exposure. Regular physical exercise 
lowers the risk of heart disease and stroke, but 
these outcomes may be adversely affected by air 
pollution exposure. In this respect, there have 
been a series of impact assessments to estimate 
the population health implications of exercising 
in air pollution and they suggest that the ben-
eficial effects of exercise outweigh the adverse 
effects of air pollution and that exercise offsets 
the adverse impacts of air pollution-related 
mortality and morbidity [105–108]. The stud-
ies were, however, not designed to look at dis-
ease onset or disease symptoms, especially in 
vulnerable groups such as COPD patients, and 
the data are far from comprehensive because 
they could not take into account confounding 
by exposure to pollutant mixtures containing 
varying concentrations of pollutants and differ-
ent exercise protocols. More research is needed 
to unravel the complex interplay between life-
style and environmental quality, but the current 
evidence supports that the risk-to-benefit ratio 
generally favours that every individual, including 
COPD patients, is encouraged to become more 
physically active and to perform regular aerobic 
exercise. Nevertheless, a greater effort should be 
made to educate patients and healthcare profes-
sionals about the risks of air pollutant exposures 
during exercise, particularly vulnerable groups 
[109]. Although no strategy has been directly 
tested to reduce morbidity and disease symp-
toms, several actions can be taken to lessen the 
degree of exposures during exercise, which may 
thereby help mitigate the adverse effects of air 
pollutants on exercise performance and possi-
ble health risk [110].
In summary, exercise training as part of a com-
prehensive pulmonary rehabilitation programme, 
can make a profound difference in the lives of 
patients with COPD. Indeed, exercise training 
reduces daily symptoms of dyspnoea and fatigue, 
improves physical fitness, reduces symptoms of 
anxiety/depression and improves quality of life in 
patients with COPD. Whether and to what extent 
an increase in (outdoor) daily physical activity 
will also improve these outcomes remains to be 
determined.
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Educational questions
1 Exercise tolerance improves following exercise-based rehabilitation in 
patients with COPD due to:
a An increased motivation
b Desensitisation to dyspnoea
c True physiological changes at the level of the lower-limb muscles
d A combination of a, b and c
2 Which statement about exercise training in patients with COPD is true:
a Exercise training improves resting lung function in patients with COPD
b Exercise training can induce significant improvements in exercise 
performance and health status in comorbid COPD patients
c Exercise training has no positive effect on comorbidities in patients with 
COPD
d Exercise training is defined as any bodily movement produced by skeletal 
muscles that results in energy expenditure
3 Which statement about pulmonary rehabilitation in patients with COPD is 
true:
a Occupational therapy is the cornerstone of pulmonary rehabilitation
b Dietary counselling is the cornerstone of pulmonary rehabilitation
c Supervised exercise training is the cornerstone of pulmonary 
rehabilitation
d Psychosocial counselling is the cornerstone of pulmonary rehabilitation
4 What is true about physical activity:
a Lower physical activity hardly occurs in patients with COPD
b Physical activity is defined as planned, structured, and repetitive 
activities and has as a final or an intermediate objective the improvement 
or maintenance of physical fitness
c Direct feedback from a pedometer or an activity monitor seems to 
be an important tool to optimise the success rate of physical activity 
counselling programmes
d Six months of Nordic walking decrease physical activity levels in patients 
with COPD
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